Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Aggarwal R, Bhatt DL, Szarek M, et al.
Lancet Diabetes Endocrinol. Pub. online 13 Feb 2025.
Leggi
Breaking news
Mechanisms of diabetic cardiomyopathy: focus on inflammation
Bellemare M, Bourcier L, Iglesies-Grau J, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
AIFA: ritiro volontario dei medicinali “GLUCOPHAGE UNIDIE 500-750-1000 mg 60 compresse a rilascio prolungato” tutti i lotti della ditta Bruno Farmaceutici SpA a seguito di segnalazione di utilizzo eccipiente idrossipropilmetilcelluosa con viscosità diversa da quella autorizzata
13/02/2025
Leggi
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
O’Donnell HK, Simmons KM, Gitelman SE, et al.
Diabetes Obes Metab. Pub. online 13 Feb 2025.
Leggi
Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study
Ehrmann D, Krause-Steinrauf H, Uschner D, et al.
Diabetologia. Pub. online 14 Feb 2025.
Leggi
Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial
Hendershot CS, Bremmer MP, Paladino MB, et al.
JAMA Psychiatry. 2025:e244789.
Leggi
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysis
Lin YM, Wu JY, Lee MC, et al.
Eur Heart J Cardiovasc Pharmacother. 2025:pvae093.
Leggi
Effect of liberal glucose control on critically ill patients: a systematic review and meta-analysis
Ma J, Wang X, Zhang Y, Ge C, et al. BMC Endocr Disord. 2025;25(1):36. Abstract e full text
Leggi
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development
Calhoun P, Spanbauer C, Steck AK, et al.
Diabetologia. Pub. online 11 Feb 2025.
Leggi
Glucose-lowering medications and risk of chronic obstructive pulmonary disease exacerbations in patients with type 2 diabetes
Ray A, Paik JM, Wexler DJ, et al.
JAMA Intern Med. 2025:e247811.
Leggi